⚡A study in Nature Medicine reports that the drug levetiracetam targets GABAergic synapses in diffuse midline glioma.

What it means

This is a study published in *Nature Medicine* showing that levetiracetam, a common anti-seizure drug, may be effective against diffuse midline glioma—a deadly childhood brain tumor—by acting on GABAergic synapses (inhibitory nerve connections) within the tumor. The paper likely explores repurposing an existing drug to target a specific vulnerability of this cancer.

Accuracy & sourcesSourced

The claim is based on a peer-reviewed primary research article in *Nature Medicine* (DOI provided), making it authoritative for its findings. Without reading the full paper we cannot confirm the exact experimental details or effect size, but the source and venue are highly credible.

How new